caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1326044819

Philip LynnM.D.

Internal MedicineGarden Grove, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
FACILITY AFFILIATIONS

Hospital & Facility Affiliations (1)

CCN 059110
Home health agency
REFERRAL NETWORK

Where Philip Lynn's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 7 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Unilab Corporation
Clinical Laboratory · West Hills, CA
1135
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
Consolidated Medical Bio-Analysis Inc
Clinical Laboratory · Cypress, CA
84149
Arthur Lu
Ophthalmology · Westminster, CA
2894
David Kramer
Cardiology · Anaheim, CA
2434
UNIVERSITY OF CALIFORNIA IRVINE2269
Thanh Phung
Diagnostic Radiology · Tustin, CA
1429
Unilab Corporation
Clinical Laboratory · West Hills, CA
1258
Medizen Advanced Imaging Inc
Independent Diagnostic Testing Facility (IDTF) · Fountain Valley, CA
1233
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,059
Unique beneficiaries
—
Total services
5,895
Distinct HCPCS
31
Medicare payment
$348K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
3,789
Beneficiaries
—
Total drug cost
$314K
Distinct drugs
83
Brand share
16.2%
Top prescribed drugs
Atorvastatin Calcium308 claims
Losartan Potassium222 claims
Amlodipine Besylate194 claims
Metformin Hcl149 claims
Rosuvastatin Calcium132 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.